In various metabolic diseases, alterations are observed in several myokines, such as interleukin-6 (IL-6), interleukin-15 (IL-15), metronin-like (Metrnl), irisin and leukemia inhibitory factor (LIF), whose levels and functions are modified, affecting energy metabolism, inflammation and interorgan communication. This evidence concerns the gene LIF and Other metabolic disease.